These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 16439306

  • 1. Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.
    van Kempen LC, Leenders WP.
    Eur J Cell Biol; 2006 Feb; 85(2):61-8. PubMed ID: 16439306
    [Abstract] [Full Text] [Related]

  • 2. Use of angiogenesis inhibitors in tumour treatment.
    Fayette J, Soria JC, Armand JP.
    Eur J Cancer; 2005 May; 41(8):1109-16. PubMed ID: 15911233
    [Abstract] [Full Text] [Related]

  • 3. The role of angiogenesis in solid tumours: an overview.
    Makrilia N, Lappa T, Xyla V, Nikolaidis I, Syrigos K.
    Eur J Intern Med; 2009 Nov; 20(7):663-71. PubMed ID: 19818284
    [Abstract] [Full Text] [Related]

  • 4. [The vascular endothelial growth factor (VEGF): a model of gene regulation and a marker of tumour aggressiveness. An obvious therapeutic target?].
    Grépin R, Pagès G.
    J Soc Biol; 2009 Nov; 203(2):181-92. PubMed ID: 19527632
    [Abstract] [Full Text] [Related]

  • 5. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R, Hamm A, Mazzone M.
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [Abstract] [Full Text] [Related]

  • 6. The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.
    van der Meel R, Symons MH, Kudernatsch R, Kok RJ, Schiffelers RM, Storm G, Gallagher WM, Byrne AT.
    Drug Discov Today; 2011 Mar; 16(5-6):219-28. PubMed ID: 21262381
    [Abstract] [Full Text] [Related]

  • 7. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
    Sato Y.
    Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
    [Abstract] [Full Text] [Related]

  • 8. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F, Ferrara N.
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeted therapies of cancer: angiogenesis inhibition seems not enough.
    Roodink I, Leenders WP.
    Cancer Lett; 2010 Dec 18; 299(1):1-10. PubMed ID: 20889254
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of angiogenesis and the angiogenesis/invasion shift.
    Bikfalvi A, Moenner M, Javerzat S, North S, Hagedorn M.
    Biochem Soc Trans; 2011 Dec 18; 39(6):1560-4. PubMed ID: 22103487
    [Abstract] [Full Text] [Related]

  • 16. The multifaceted activity of VEGF in angiogenesis - Implications for therapy responses.
    Moens S, Goveia J, Stapor PC, Cantelmo AR, Carmeliet P.
    Cytokine Growth Factor Rev; 2014 Aug 18; 25(4):473-82. PubMed ID: 25169850
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor receptors: expression and function in solid tumors.
    Wey JS, Stoeltzing O, Ellis LM.
    Clin Adv Hematol Oncol; 2004 Jan 18; 2(1):37-45. PubMed ID: 16163158
    [Abstract] [Full Text] [Related]

  • 18. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
    Hicklin DJ, Ellis LM.
    J Clin Oncol; 2005 Feb 10; 23(5):1011-27. PubMed ID: 15585754
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.